Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-28 @ 8:20 PM
Study NCT ID:
NCT05017103
Status:
TERMINATED
Last Update Posted:
2024-12-11
First Post:
2021-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-20
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-17
First Submit QC Date:
None
Study First Post Date:
2021-08-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-10
Results First Submit QC Date:
None
Results First Post Date:
2024-11-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-12-11
Last Update Post Date Type:
ACTUAL